HHS permits pharmacies to compound six popular unapproved peptides

The Department of Health and Human Services has decided to allow small compounding pharmacies to produce six peptides that have not been approved by the FDA. This move aims to increase availability, though it may still fall short of meeting overall demand. The decision reflects ongoing challenges in peptide accessibility and regulation.

Originally published by npr